Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 16 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 13 14 15 16 presentations: 1 to 50 of 789
INDEX FACTORS INCREASE PARTNER NOTIFICATION YIELD FOR KENYAN PEOPLE WHO INJECT DRUGS   (ABSTRACT 42)
Brandon Guthrie
University of Washington, Seattle, WA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
COMMUNITY-BASED MULTIMONTH DISPENSING OF ART: A CLUSTER RANDOMISED TRIAL IN LESOTHO   (ABSTRACT 43)
Betty Bawuba Tukei
Right to Care, Maseru, Lesotho
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
AN MHEALTH CHW INTERVENTION TRIAL IN AN HIV HYPERENDEMIC COMMUNITY IN RAKAI, UGANDA   (ABSTRACT 44)
Larry W Chang
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
IMPROVED TIME IN CARE AND VIRAL SUPPRESSION WITH STREAMLINED CARE IN THE SEARCH STUDY   (ABSTRACT 45)
Matthew D Hickey
University of California San Francisco, San Francisco, CA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
COLLABORATIVE DATA-TO-CARE MODEL IMPROVES HIV CARE OUTCOMES IN PLWH IN PHILADELPHIA   (ABSTRACT 46)
Kathleen Anne Brady
Philadelphia Department of Public Health, Philadelphia, PA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
POPULATION-LEVEL VIREMIA PREDICTS HIV INCIDENCE ACROSS UNIVERSAL TEST & TREAT STUDIES   (ABSTRACT 47)
Maya L Petersen
University of California, Berkeley, Berkeley, CA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
DECREASING COMMUNITY VIREMIA IS ASSOCIATED WITH DECREASING HIV INCIDENCE IN AUSTRALIA   (ABSTRACT 48)
Denton James Callander
UNSW Sydney, Sydney, NSW, Australia
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
COMMUNITY ART INCREASES VIRAL SUPPRESSION AND ELIMINATES DISPARITIES FOR AFRICAN MEN   (ABSTRACT 49)
Ruanne V Barnabas
University of Washington, Seattle, WA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
SINGLE-CELL GENOMIC ANALYSIS OF BLOOD AND CSF T CELLS IN HIV+ AND HIV– ADULTS   (ABSTRACT 27)
Shelli Farhadian
Yale School of Medicine, New Haven, CT, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
GREATER BURDEN OF INTRACRANIAL ARTERIAL-WALL ENHANCEMENT IN PERSONS LIVING WITH HIV   (ABSTRACT 28)
Felicia C Chow
University of California San Francisco, San Francisco, CA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
PET IMAGING OF SYNAPTIC DENSITY IN HIV: PRELIMINARY FINDINGS FROM A PILOT STUDY   (ABSTRACT 29)
Julian Weiss
Yale University, New Haven, CT, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
HIV-INFECTED MACROPHAGES EVADE NK CELL-MEDIATED KILLING WHILE DRIVING INFLAMMATION   (ABSTRACT 30)
Kiera L Clayton
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
HIV DNA DETECTED IN IMMUNE CELL SUBSETS IN CSF DURING ART   (ABSTRACT 31)
Joshua Charles Cyktor
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
EFFECTS OF HIV AND AGING ON RESTING-STATE NETWORKS   (ABSTRACT 32)
Patrick Luckett
Washington University in St Louis, St Louis, MO, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
MYELIN CONTENT IS ELEVATED IN VIROLOGICALLY UNSUPPRESSED PEOPLE LIVING WITH HIV   (ABSTRACT 33)
Dimitre Tomov
Washington University, St Louis, MO, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
CABOTEGRAVIR + RILPIVIRINE EVERY 2 MONTHS IS NONINFERIOR TO MONTHLY: ATLAS-2M STUDY   (ABSTRACT 34)
Edgar Turner Overton
University of Alabama, Birmingham, AL, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
PROSPECTIVE ENHANCED MONITORING OF DOLUTEGRAVIR-BASED FIRST LINE IN MALAWI   (ABSTRACT 35)
Elvis Temfack
Medecins Sans Frontieres, Blantyre, Malawi
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
RANDOMIZED SWITCH TO B/F/TAF IN AFRICAN AMERICAN ADULTS WITH HIV   (ABSTRACT 36)
Debbie P Hagins
Chatham CARE Center, Savannah, GA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
IMPACT OF ANTI-PD-1 AND ANTI-CTLA-4 ON THE HIV RESERVOIR IN VIVO: THE AMC-095 STUDY   (ABSTRACT 37)
Thomas Aagaard Rasmussen
University of Melbourne, Melbourne, Victoria, Australia
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
A RANDOMIZED TRIAL OF THE IMPACT OF 3BNC117 AND ROMIDEPSIN ON THE HIV-1 RESERVOIR   (ABSTRACT 38)
Ole Schmeltz Søgaard
Aarhus University Hospital, Aarhus N, Denmark
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
SAFETY & PHARMACOKINETICS OF GS-9722 IN HIV-NEGATIVE PARTICIPANTS AND PEOPLE WITH HIV   (ABSTRACT 39)
Peter Ruane
Peter J Ruane, MD Inc, Los Angeles, CA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
SAFETY AND ANALYTIC TREATMENT INTERRUPTION OUTCOMES OF VESATOLIMOD IN HIV CONTROLLERS   (ABSTRACT 40)
Devi Sengupta
Gilead Sciences, Foster City, CA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
DURABLE HIV-1 ANTIBODY PRODUCTION IN HUMANS AFTER AAV8-MEDIATED GENE TRANSFER   (ABSTRACT 41)
Joseph P Casazza
National Institutes of Health, USA, Bethesda, MD, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
MECHANISMS OF PSGL-1 AND CD43 RESTRICTION OF HIV INFECTION OF CD4 T CELLS   (ABSTRACT 19)
Yuntao Wu
George Mason University, Manassas, VA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
STRUCTURAL ANALYSES OF A BOUND ANTI-CD4 ADNECTIN INHIBITOR OF HIV-1   (ABSTRACT 20)
David Wensel
ViiV Healthcare, Branford, CT, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
SERINC3/5 PERTURB HIV MEMBRANE FUSION POST-HEMIFUSION AT FUSION-PORE DILATION STEPS   (ABSTRACT 21)
Amanda E Ward
University of Virginia, Charlottesville, VA, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
CRISPR-INDUCED MUTAGENESIS POINTS TOWARD A ROLE OF TRN-SR2 IN HIV NUCLEAR IMPORT   (ABSTRACT 22)
Frauke Christ
Katholieke University Leuven, Leuven, Belgium
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
NUCLEAR UNCOATING OF HIV-1 OCCURS NEAR SITES OF INTEGRATION   (ABSTRACT 23)
Ryan C Burdick
National Cancer Institute, Frederick, MD, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
RECONSTITUTION OF HIV-1 CAPSID-DEPENDENT REPLICATION AND INTEGRATION IN VITRO   (ABSTRACT 24)
Devin E Christensen
University of Utah, Salt Lake City, UT, USA
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
STRUCTURAL BASIS OF SECOND-GENERATION HIV INTEGRASE INHIBITOR ACTION AND VIRUS ESCAPE   (ABSTRACT 25)
Peter Cherepanov
Francis Crick Institute, London, United Kingdom
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
THE CHROMATIN LANDSCAPE AT THE HIV-1 INTEGRATION SITE DETERMINES VIRAL EXPRESSION   (ABSTRACT 26)
Zeger Debyser
KU Leuven, Leuven, Belgium
from CROI 2020 on March 9, 2020 10:00 AM-12:00 PM
A MENDELIAN RANDOMIZATION ANALYSIS OF PROTEIN BIOMARKERS AND CVD IN PERSONS WITH HIV   (ABSTRACT 80)
Cavan Reilly
University of Minnesota, Minneapolis, MN, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
RISKS OF METABOLIC SYNDROME, DIABETES, AND CARDIOVASCULAR DISEASE IN ADVANCE TRIAL   (ABSTRACT 81)
Andrew Hill
University of Liverpool, Liverpool, United Kingdom
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
CYP2B6 GENOTYPE AND WEIGHT-GAIN DIFFERENCES BETWEEN DOLUTEGRAVIR AND EFAVIRENZ   (ABSTRACT 82)
Rulan Griesel
University of Cape Town, Cape Town, Western Cape, South Africa
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
CHANGES IN BODY MASS INDEX AND THE RISK OF CARDIOVASCULAR DISEASE: THE D:A:D STUDY   (ABSTRACT 83)
Kathy Petoumenos
The Kirby Institute, UNSW Sydney, Sydney, Australia
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
LOSARTAN TO REDUCE INFLAMMATION AND FIBROSIS ENDPOINTS IN HIV DISEASE (LIFE-HIV)   (ABSTRACT 84)
Jason V Baker
Hennepin Healthcare Research Institute, Minneapolis, MN, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
EFFECTS OF HIV INFECTION AND IMMUNE REGULATION ON LONGITUDINAL LUNG FUNCTION DECLINE   (ABSTRACT 85)
Jing Sun
Johns Hopkins University, Baltimore, MD, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
AZITHROMYCIN FOR TREATMENT OF HIV-RELATED CHRONIC LUNG DISEASE IN AFRICAN CHILDREN   (ABSTRACT 86)
Rashida Abbas Ferrand
London School of Hygiene and Tropical Medicine, London, United Kingdom
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
TARGETING THE KSHV TYROSINE KINASE AND VIRAL LYTIC REACTIVATION WITH INHIBITORS   (ABSTRACT 64)
Thomas F. Schulz
Medizinische Hochschule Hannover, Hannover, Germany
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
A ROLE FOR IRON METABOLISM AND FERROPTOSIS IN KAPOSI SARCOMA HERPESVIRUS PATHOGENESIS   (ABSTRACT 65)
Ashlee Vivien Moses
Oregon Health & Science University, Beaverton, OR, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
GENE EXPRESSION PATTERNS IN SKIN VS GASTROINTESTINAL KAPOSI SARCOMA LESIONS   (ABSTRACT 66)
Joseph Ziegelbauer
National Institutes of Health, Bethesda, MD, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
IMPACT OF VALGANCICLOVIR THERAPY ON SEVERE IRIS–KAPOSI SARCOMA–ATTRIBUTABLE MORTALITY   (ABSTRACT 67)
Patricia Volkow
Instituto Nacional de Cancerologia, Mexico City, Mexico
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
SURVEILLANCE OF RHESUS MACAQUE TISSUES IDENTIFYING GAMMAHERPESVIRUS INFECTION SITES   (ABSTRACT 68)
Catherine Brands
Frederick National Laboratory for Cancer Research, Frederick, MD, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
CONJUNCTIVAL CANCER IN PEOPLE LIVING WITH HIV: THE SAM STUDY   (ABSTRACT 69)
Tafadzwa G Dhokotera
Institute of Social and Preventative Medicine, University of Bern, Switzerland, Bern, Switzerland
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
CLEARANCE OF HPV ANAL HIGH-GRADE INTRAEPITHELIAL LESIONS WITH LOW-DOSE POMALIDOMIDE   (ABSTRACT 70)
Mark Polizzotto
The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
INCREASED CANCER RISK WITH LOWER CD4/CD8 RATIO AMONG ADULTS WITH HIV IN NA-ACCORD   (ABSTRACT 71)
Jessica L. Castilho
Vanderbilt University Medical Center, Nashville, TN, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
BIC/FTC/TAF POSTEXPOSURE PROPHYLAXIS PROTECTS MACAQUES AGAINST RECTAL SHIV INFECTION   (ABSTRACT 87)
Elena Bekerman
Gilead Sciences Inc, Foster City, CA, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
ON-DEMAND HIV POSTEXPOSURE PROPHYLAXIS BY TAF/EVG VAGINAL INSERTS IN MACAQUES   (ABSTRACT 88)
Charles Dobard
CDC, atlanta, GA, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
WEEKLY ORAL ISLATRAVIR PROVIDES EFFECTIVE PEP AGAINST IV CHALLENGE WITH SIVMAC251   (ABSTRACT 89)
Jay Grobler
Merck & Co, West Point, PA, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
PHASE I PLACEBO-CONTROLED SAFETY, PK, AND PD STUDY OF MB66 ANTI-HIV AND ANTI-HSV FILM   (ABSTRACT 90)
Susan Cu-Uvin
The MIriam Hospital, Providence, RI, USA
from CROI 2020 on March 10, 2020 10:00 AM-12:00 PM
<< first | < prev page: of 16 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 13 14 15 16 presentations: 1 to 50 of 789